In the past week, WGS stock has gone up by 3.68%, with a monthly decline of -41.16% and a quarterly plunge of -16.23%. The volatility ratio for the week is 6.62%, and the volatility levels for the last 30 days are 8.36% for GeneDx Holdings Corp The simple moving average for the past 20 days is -26.39% for WGS’s stock, with a -14.11% simple moving average for the past 200 days.
Is It Worth Investing in GeneDx Holdings Corp (NASDAQ: WGS) Right Now?
WGS has 36-month beta value of 1.95. Analysts have mixed views on the stock, with 4 analysts rating it as a “buy,” 0 as “overweight,” 3 as “hold,” and 0 as “sell.”
The public float for WGS is 24.98M, and currently, short sellers hold a 14.30% ratio of that float. The average trading volume of WGS on May 15, 2025 was 1.22M shares.
WGS) stock’s latest price update
The stock price of GeneDx Holdings Corp (NASDAQ: WGS) has plunged by -2.43 when compared to previous closing price of 60.93, but the company has seen a 3.68% gain in its stock price over the last five trading sessions. seekingalpha.com reported 2025-05-14 that GeneDx’s recent 50% stock drop post-Q1 earnings is seen as an overreaction, despite a projected modest growth slowdown from 42% to 30-35%. The company is expanding product lines, improving margins, and increasing insurance coverage, with the recent acquisition of Fabric Genomics offering growth and cost synergies. GeneDx’s valuation is attractive compared to peers, with a forward P/E of 30 and projected profitability next year, unlike Natera and Tempus AI.
Analysts’ Opinion of WGS
Many brokerage firms have already submitted their reports for WGS stocks, with Jefferies repeating the rating for WGS by listing it as a “Buy.” The predicted price for WGS in the upcoming period, according to Jefferies is $80 based on the research report published on May 09, 2025 of the current year 2025.
Wells Fargo, on the other hand, stated in their research note that they expect to see WGS reach a price target of $34. The rating they have provided for WGS stocks is “Equal Weight” according to the report published on August 28th, 2024.
Craig Hallum gave a rating of “Buy” to WGS, setting the target price at $43 in the report published on July 10th of the previous year.
WGS Trading at -32.78% from the 50-Day Moving Average
After a stumble in the market that brought WGS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -49.51% of loss for the given period.
Volatility was left at 8.36%, however, over the last 30 days, the volatility rate increased by 6.62%, as shares sank -41.84% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -39.95% lower at present.
During the last 5 trading sessions, WGS rose by +3.68%, which changed the moving average for the period of 200-days by +77.30% in comparison to the 20-day moving average, which settled at $80.76. In addition, GeneDx Holdings Corp saw -22.65% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at WGS starting from Meister Keith A., who purchase 100,000 shares at the price of $56.01 back on May 08 ’25. After this action, Meister Keith A. now owns 3,008,629 shares of GeneDx Holdings Corp, valued at $5,600,994 using the latest closing price.
Feeley Kevin, the CHIEF FINANCIAL OFFICER of GeneDx Holdings Corp, sale 388 shares at $113.09 during a trade that took place back on Apr 29 ’25, which means that Feeley Kevin is holding 3,337 shares at $43,879 based on the most recent closing price.
Stock Fundamentals for WGS
Current profitability levels for the company are sitting at:
- -0.04 for the present operating margin
- 0.64 for the gross margin
The net margin for GeneDx Holdings Corp stands at -0.12. The total capital return value is set at -0.04. Equity return is now at value -16.61, with -9.17 for asset returns.
Based on GeneDx Holdings Corp (WGS), the company’s capital structure generated 0.31 points at debt to capital in total, while cash flow to debt ratio is standing at -0.02. The debt to equity ratio resting at 0.45. The interest coverage ratio of the stock is -13.34.
Currently, EBITDA for the company is -23.21 million with net debt to EBITDA at -0.74. When we switch over and look at the enterprise to sales, we see a ratio of 5.18. The receivables turnover for the company is 7.17for trailing twelve months and the total asset turnover is 0.74. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.25.
Conclusion
To put it simply, GeneDx Holdings Corp (WGS) has had a mixed performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
